SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-21-007983
Filing Date
2021-08-26
Accepted
2021-08-26 19:29:53
Documents
1
Period of Report
2021-08-24

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 10141
  Complete submission text file 0001062993-21-007983.txt   11622
Mailing Address 1000 SECOND AVENUE SUITE 3700 SEATTLE WA 98104
Business Address
McIlwain Matthew S (Reporting) CIK: 0001381752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 211213773

Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks